OTC SquawkOTC Squawk
Log inSign up
OTC SquawkOTC Squawk
Log inSign up
FeedDiscoverTickersNotificationsProfileSign in to squawk

OTC Squawk is not affiliated with, endorsed by, or sponsored by OTC Markets Group Inc. All trademarks are the property of their respective owners.

$ENZC

OTCID

ENZOLYTICS INC

Sign in to follow
OTC
Exchange
Healthcare
Sector
Biotechnology
Industry
Common Stock
Security type
4.83B
Shares outstanding
294112107
CUSIP
ENZC
Symbol

Company and security reference data from OTC Markets Group.

SEC filings
Last trade

Catalysts

  • 8-K
    Current report
    SEC · Apr 16, 2020
  • 8-K
    Current report
    SEC · Aug 13, 2019
  • 10-Q
    Quarterly report
    SEC · Sep 15, 2017
  • 15-15D
    View filing
    SEC · Nov 8, 2011
  • 10-Q/A
    Quarterly report (amended)
    SEC · Nov 1, 2011
  • 10-K/A
    Annual report (amended)
    SEC · Nov 1, 2011
  • 10-Q
    Quarterly report
    SEC · May 23, 2011
  • 10-K
    Annual report
    SEC · May 19, 2011

DD entries are user-generated due diligence, not investment advice. Moderated. Filings link to sec.gov.

Be the first to squawk $ENZC

No squawks on $ENZC yet. Kick off the conversation.

Sign in to squawk $ENZC

Top contributors

  • 1@Wili
    Wili
    @Wili
    90
    motion
  • 2@TophatTopher
    TophatTopher
    @TophatTopher
    88
    motion
  • 3@otcsetGuy
    otcset Guy
    @otcsetGuy
    87
    motion
  • 4@Stevemcgregor0209
    SteveMcgregor
    @Stevemcgregor0209
    85
    motion
  • 5T
    Russ
    @TheBigRuss77
    84
    motion

Related tickers

  • $XPHYFXphyto Therapeutics Corp
  • $CGCCanopy Growth Corp
  • $MMNFFMedMen Enterprises Inc
  • $KALYKALI INC
  • $SNDLSNDL Inc

Dilution indicators

No level shown - warrant disclosures and preferred stock disclosures could not be read reliably from this filing. The extracted facts are below.

Shares outstanding
29,599,433
Shares authorized
1,000,000,000
Authorized headroom
970,400,567 (32.8x outstanding)
Convertible note principal
$35,000
Conversion discount
Not read reliably
Shares issuable from convertibles
100,000
Warrants outstanding
Not read reliably
Preferred shares outstanding
Not read reliably
Preferred conversion shares
Not read reliably

From 10-Q filed Sep 15, 2017View filing

How this is calculated

Level = disclosed potential new shares (warrants + preferred conversion shares + shares issuable from convertible notes, where the filing states them) divided by shares outstanding:

under 10% = Low · 10-50% = Moderate · 50-200% = Elevated · over 200% = Substantial

Only figures stated explicitly in the filing are used - nothing is estimated. A level is shown only when the share count was read with high confidence AND each of convertibles, warrants, and preferred stock was either clearly disclosed or affirmatively stated as none by the filing. If any of the three could not be read reliably, no level is shown at all - partial data never produces a label. Authorized headroom is shown as a separate fact and is not part of the level. Convertible note principal (dollars) is never converted into shares.

Figures are AI-extracted from the company's own SEC filings and may contain errors - always verify against the linked filing. This is not investment advice.